Nebenwirkungen · Jascayd
Jascayd 9 mg film-coated tablets Jascayd 18 mg film-coated tablets · Abschnitt 4.8 · PDF-Seite 7
HOS-152815 · Präparat HOS-100843
System Organ Class Adverse reactions Frequency category IPFb PPF Metabolism and nutrition disorders Decreased Common Common appetite Gastrointestinal disorders Diarrhoeaa Very Very common common Nausea Common Common Musculoskeletal and connective tissue Back pain Common Common disorders Investigations Weight Common Common decreaseda a see section Description of selected adverse reactions b Frequencies were calculated excluding patients in the 9 mg dose group receiving concomitantly pirfenidone, as this combination is not recommended due to a clinically relevant drug-drug interaction (see section 4.2 and section 4.5).
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-07-21T08:34:55Z · SHA-256 57790d233138c65fd6d481415ca8b09c40ab04d92c89d127ce18d12510d03c97 · Passage a2e8b44b317929d5280c10e933a15840ea88b8567250d243e14e3ab1f550f14f · Zeichen 719–1900 im Abschnitt